Venture capital investors poured billions into the spine surgery industry from 2000 to 2023, according to a study in the January 2025 issue of The Spine Journal.
Five notes:
1. Researchers analyzed 1,001 venture capital investments in the PitchBook database across 227 spine surgery companies.
2. Investments were categorized into five groups: surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services.
3. A total $5.3 billion was invested in spine surgery, and nonsurgical devices saw the lion's share of 42.6%.
4. Surgical device investments made up 26.3% of that $5.3 billion, and biotechnology saw 22.2% of the share.
5. Annual investments increased by 1,782%, but there was a decline in 2023. That decline was "likely due to macroeconomic factors," the study said.